{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:42:04Z","timestamp":1791852124472,"version":"4.3.4"},"reference-count":267,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>This review provides an overview of the most important novel treatment strategies against Streptococcus pneumoniae infections published over the past 10 years. The pneumococcus causes the majority of community-acquired bacterial pneumonia cases, and it is one of the prime pathogens in bacterial meningitis. Over the last 10 years, extensive research has been conducted to prevent severe pneumococcal infections, with a major focus on (i) boosting the host immune system and (ii) discovering novel antibacterials. Boosting the immune system can be done in two ways, either by actively modulating host immunity, mostly through administration of selective antibodies, or by interfering with pneumococcal virulence factors, thereby supporting the host immune system to effectively overcome an infection. While several of such experimental therapies are promising, few have evolved to clinical trials. The discovery of novel antibacterials is hampered by the high research and development costs versus the relatively low revenues for the pharmaceutical industry. Nevertheless, novel enzymatic assays and target-based drug design, allow the identification of targets and the development of novel molecules to effectively treat this life-threatening pathogen.<\/jats:p>","DOI":"10.1093\/femsre\/fuaa072","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T20:08:08Z","timestamp":1609531688000},"source":"Crossref","is-referenced-by-count":29,"title":["The search for novel treatment strategies for<i>Streptococcus pneumoniae<\/i>infections"],"prefix":"10.1093","author":[{"given":"F","family":"Cools","sequence":"first","affiliation":[{"name":"Laboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Delputte","sequence":"additional","affiliation":[{"name":"Laboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-8911","authenticated-orcid":false,"given":"P","family":"Cos","sequence":"additional","affiliation":[{"name":"Laboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"2021013001451338000_bib1","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/jac\/dkv163","article-title":"Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections","volume":"70","author":"Aguinagalde","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021013001451338000_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.btre.2019.e00385","article-title":"Protective responses of an engineered PspA recombinant antigen against Streptococcus pneumoniae","volume":"24","author":"Akbari","year":"2019","journal-title":"Biotechnol Reports"},{"key":"2021013001451338000_bib3","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1073\/pnas.1401011111","article-title":"Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection","volume":"111","author":"Ali","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021013001451338000_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jinf.2017.03.005","article-title":"Pneumolysin as a potential therapeutic target in severe pneumococcal disease","volume":"74","author":"Anderson","year":"2017","journal-title":"J Infect"},{"key":"2021013001451338000_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00224","article-title":"Role of Streptococcus pneumoniae proteins in evasion of complement-mediated immunity","volume":"8","author":"Andre","year":"2017","journal-title":"Front Microbiol"},{"key":"2021013001451338000_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/JB.181.2.483-492.1999","article-title":"Use of genomics to identify bacterial undecaprenyl pyrophosphate synthetase: Cloning, expression, and characterization of the essential uppS gene","volume":"181","author":"Apfel","year":"1999","journal-title":"J Bacteriol"},{"key":"2021013001451338000_bib7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJMcibr1500292","article-title":"A new antibiotic and the evolution of resistance","volume":"372","author":"Arias","year":"2015","journal-title":"N Engl J Med"},{"key":"2021013001451338000_bib8","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/cbic.201500091","article-title":"Direct Staudinger-phosphonite reaction provides methylphosphonamidates as inhibitors of CE4 De-N-acetylases","volume":"16","author":"Ariyakumaran","year":"2015","journal-title":"ChemBioChem"},{"key":"2021013001451338000_bib64_459_1611034152619","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.toxicon.2010.12.009","article-title":"Allicin from garlic neutralizes the hemolytic activity of intra- and extra-cellular pneumolysin O in vitro","volume":"57","author":"Arzanlou","year":"2011","journal-title":"Toxicon"},{"key":"2021013001451338000_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1021\/cb501032x","article-title":"Discovery of novel pneumococcal surface antigen A (PsaA) inhibitors using a fragment-based drug design approach","volume":"10","author":"Bajaj","year":"2015","journal-title":"ACS Chem Biol"},{"key":"2021013001451338000_bib10","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/AAC.00742-13","article-title":"Immunoactivating peptide P4 augments alveolar macrophage phagocytosis in two diverse human populations","volume":"57","author":"Bangert","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi45_383_154621","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/jac\/dkz119","article-title":"Potential of the fluoroketolide RBx 14255 against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae in an experimental murine meningitis model","volume":"74","author":"Barman","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2021013001451338000_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-016-0777-5","article-title":"Clinical Streptococcus pneumoniae isolates induce differing CXCL8 responses from human nasopharyngeal epithelial cells which are reduced by liposomes","volume":"16","author":"Baumgartner","year":"2016","journal-title":"BMC Microbiol"},{"key":"2021013001451338000_bib12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"2021013001451338000_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40136-017-0152-6","article-title":"Streptococcus pneumoniae otitis media pathogenesis and how it informs our understanding of vaccine strategies","volume":"5","author":"Bergenfelz","year":"2017","journal-title":"Curr Otorhinolaryngol Rep"},{"key":"2021013001451338000_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/QCO.0000000000000416","article-title":"Novel and preclinical treatment strategies in pneumococcal meningitis","volume":"31","author":"Bewersdorf","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2021013001451338000_bib16","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/AAC.02820-15","article-title":"In vitro activity of gepotidacin, a novel triazaacenaphthylene bacterial topoisomerase inhibitor, against a broad spectrum of bacterial pathogens","volume":"60","author":"Biedenbach","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612820666140905114627","article-title":"Quorum sensing inhibitors as anti-biofilm agents","volume":"21","author":"Brackman","year":"2014","journal-title":"Curr Pharm Des"},{"key":"2021013001451338000_bib18","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021013001451338000_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00212","article-title":"Divergent roles for TRAIL in lung diseases","volume":"5","author":"Braithwaite","year":"2018","journal-title":"Front Med"},{"key":"2021013001451338000_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0028-2018","article-title":"Pneumococcal vaccines","volume":"7","author":"Briles","year":"2019","journal-title":"Microbiol Spectr"},{"key":"2021013001451338000_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01366","article-title":"Streptococcus pneumoniae\u2019s virulence and host immunity: Aging, diagnostics, and prevention","volume":"9","author":"Brooks","year":"2018","journal-title":"Front Immunol"},{"key":"2021013001451338000_bib22","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1128\/IAI.70.8.4389-4398.2002","article-title":"Characterization of pit, a Streptococcus pneumoniae iron uptake ABC transporter","volume":"70","author":"Brown","year":"2002","journal-title":"Infect Immun"},{"key":"2021013001451338000_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bcp.2011.03.028","article-title":"Development of screening assays and discovery of initial inhibitors of pneumococcal peptidoglycan deacetylase PgdA","volume":"82","author":"Bui","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"2021013001451338000_doi22_729_152421","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bmcl.2010.11.079","article-title":"Discovery of novel ureas and thioureas of 3-decladinosyl-3-hydroxy 15-membered azalides active against efflux-mediated resistant Streptococcus pneumoniae","volume":"21","author":"Bukvi\u0107\u00a0Kraja\u010di\u0107","year":"2011","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41429-020-0291-8","article-title":"Antibiotics in the clinical pipeline in October 2019","volume":"73","author":"Butler","year":"2020","journal-title":"J Antibiot (Tokyo)"},{"key":"2021013001451338000_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/14787210.2019.1694905","article-title":"Biological challenges of phage therapy and proposed solutions: A literature review","volume":"17","author":"Caflisch","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2021013001451338000_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2042-6410-4-16","article-title":"Sex and inflammation in respiratory diseases: a clinical viewpoint","volume":"4","author":"Casimir","year":"2013","journal-title":"Biol Sex Differ"},{"key":"2021013001451338000_bib27","volume-title":"Antibiotic resistance threats in the United States","author":"Centre for Disease Control (CDC)","year":"2013"},{"key":"2021013001451338000_bib28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00405-014-2942-5","article-title":"Preliminary results of a novel quorum sensing inhibitor against pneumococcal infection and biofilm formation with special interest to otitis media and cochlear implantation","volume":"272","author":"Cevizci","year":"2015","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"2021013001451338000_doi1_842_155221","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/cmdc.201300011","article-title":"Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria","volume":"8","author":"Chang","year":"2013","journal-title":"ChemMedChem"},{"key":"2021013001451338000_bib29","article-title":"Structures of Streptococcus pneumoniae PiaA and its complex with ferrichrome reveal insights into the substrate binding and release of high affinity iron transporters","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"key":"2021013001451338000_doi24_584_152521","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/j.bmcl.2012.10.064","article-title":"Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib30","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1097\/MJT.0000000000000551","article-title":"Antimicrobial resistant Streptococcus pneumoniae","volume":"24","author":"Cherazard","year":"2017","journal-title":"Am J Ther"},{"key":"2021013001451338000_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ja.2016.52","article-title":"Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics","volume":"70","author":"Cherian","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"2021013001451338000_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21614-4","article-title":"A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK","volume":"8","author":"Chiarelli","year":"2018","journal-title":"Sci Rep"},{"key":"2021013001451338000_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00284-016-1166-x","article-title":"Phage therapy in bacterial infections treatment: One hundred years after the discovery of bacteriophages","volume":"74","author":"Cisek","year":"2017","journal-title":"Curr Microbiol"},{"key":"2021013001451338000_bib34","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1021\/acs.jmedchem.6b00746","article-title":"Discovery and characterization of a class of pyrazole inhibitors of bacterial undecaprenyl pyrophosphate synthase","volume":"59","author":"Concha","year":"2016","journal-title":"J Med Chem"},{"key":"2021013001451338000_doi17_982_151821","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.ejmech.2011.04.004","article-title":"Synthesis and antibacterial activity of novel 4\u2033-O-benzimidazolyl clarithromycin derivatives","volume":"46","author":"Cong","year":"2011","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/fty069","article-title":"Streptococcus pneumoniae galU gene mutation has a direct effect on biofilm growth, adherence and phagocytosis in vitro and pathogenicity in vivo","volume":"76","author":"Cools","year":"2018","journal-title":"Pathog Dis"},{"key":"2021013001451338000_bib36","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3389\/fmicb.2020.01596","article-title":"In vitro and in vivo evaluation of in silico predicted pneumococcal UDPG:PP inhibitors","volume":"11","author":"Cools","year":"2020","journal-title":"Front Microbiol"},{"key":"2021013001451338000_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nchembio.1382","article-title":"Imperfect coordination chemistry facilitates metal ion release in the Psa permease","volume":"10","author":"Cou\u00f1ago","year":"2014","journal-title":"Nat Chem Biol"},{"key":"2021013001451338000_doi28_931_153121","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/jac\/dkt217","article-title":"A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia","volume":"68","author":"Covington","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2021013001451338000_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/np5000796","article-title":"New horizons for old drugs and drug leads","volume":"77","author":"Cragg","year":"2014","journal-title":"J Nat Prod"},{"key":"2021013001451338000_bib70_754_1611060823516","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1128\/AAC.00524-16","article-title":"Macrolones are a novel class of macrolide antibiotics active against key resistant respiratory pathogens in vitro and in vivo","volume":"60","author":"\u010cip\u010di\u0107\u00a0Paljetak","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pro.2579","article-title":"Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase","volume":"24","author":"Danley","year":"2015","journal-title":"Protein Sci"},{"key":"2021013001451338000_bib40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4049\/jimmunol.1400133","article-title":"Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization","volume":"193","author":"Das","year":"2014","journal-title":"J Immunol"},{"key":"2021013001451338000_bib60","doi-asserted-by":"crossref","first-page":"13673","DOI":"10.1002\/anie.201505700","article-title":"Aromatic esters of bicyclic amines as antimicrobials against Streptococcus pneumoniae","volume":"54","author":"De\u00a0Gracia\u00a0Retamosa","year":"2015","journal-title":"Angew Chemie - Int Ed"},{"key":"2021013001451338000_bib79","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1128\/AAC.01661-13","article-title":"Discovery of inhibitors of 4\u2019-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy","volume":"57","author":"De\u00a0Jonge","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/14787210.2013.814831","article-title":"Streptococcus pneumoniae infection: a Canadian perspective","volume":"11","author":"Deng","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2021013001451338000_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkv038","article-title":"A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae","volume":"70","author":"Diez-Martinez","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021013001451338000_bib43","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1016\/j.bmc.2018.10.008","article-title":"Monosaccharide inhibitors targeting carbohydrate esterase family 4 de-N-acetylases","volume":"26","author":"DiFrancesco","year":"2018","journal-title":"Bioorganic Med Chem"},{"key":"2021013001451338000_bib44","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.4049\/jimmunol.171.10.5380","article-title":"Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection","volume":"171","author":"Dockrell","year":"2003","journal-title":"J Immunol"},{"key":"2021013001451338000_bib45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.12-0210","article-title":"Pneumococcal pneumonia: Mechanisms of infection and resolution","volume":"142","author":"Dockrell","year":"2012","journal-title":"Chest"},{"key":"2021013001451338000_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01992-16","article-title":"N-Acetyl-L-cysteine and cysteamine as new strategies against mixed biofilms of nonencapsulated Streptococcus pneumoniae and nontypeable Haemophilus influenzae","volume":"61","author":"Domenech","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib47","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/IAI.00491-13","article-title":"Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae","volume":"81","author":"Domenech","year":"2013","journal-title":"Infect Immun"},{"key":"2021013001451338000_doi42_649_154421","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1128\/AAC.01066-13","article-title":"Mechanism of action of the novel aminomethylcycline antibiotic omadacycline","volume":"58","author":"Draper","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi34_388_153821","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/AAC.00322-11","article-title":"Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant","volume":"55","author":"Dugourd","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijantimicag.2018.11.010","article-title":"Antibiotic discovery: History, methods and perspectives","volume":"53","author":"Durand","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"2021013001451338000_bib49","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/AAC.05485-11","article-title":"Pyrrolamide DNA gyrase inhibitors: Fragment-based nuclear magnetic resonance screening to identify antibacterial agents","volume":"56","author":"Eakin","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib50","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1021\/bi0496945","article-title":"Crystal structure of Escherichia coli cytidine triphosphate synthetase, a nucleotide-regulated glutamine amidotransferase\/ATP-dependent amidoligase fusion protein and homologue of anticancer and antiparasitic drug targets","volume":"43","author":"Endrizzi","year":"2004","journal-title":"Biochemistry"},{"key":"2021013001451338000_bib51","volume-title":"Surveillance of Antimicrobial Resistance in Europe 2018","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2019"},{"key":"2021013001451338000_bib61_120_1611031751597","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1016\/j.ejmech.2011.05.002","article-title":"Synthesis, activity and pharmacokinetics of novel antibacterial 15-membered ring macrolones","volume":"46","author":"Fajdeti\u0107","year":"2011","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/nrmicro1004","article-title":"Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies","volume":"2","author":"Fang","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"2021013001451338000_doi31_420_153321","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1128\/AAC.04568-14","article-title":"Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012","volume":"59","author":"Farrell","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi27_481_153021","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1128\/AAC.00471-11","article-title":"Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections","volume":"55","author":"Fernandez","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of community-acquired pneumonia and unmet clinical needs","author":"Ferreira-Coimbra","year":"2020","journal-title":"Adv Ther"},{"key":"2021013001451338000_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00468-17","article-title":"Gepotidacin (GSK2140944) in vitro activity against Gram-positive and Gram-negative bacteria","volume":"61","author":"Flamm","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi52_895_155321","article-title":"In vitro activity of the novel lactone ketolide nafithromycin (WCK 4873) against contemporary clinical bacteria from a global surveillance program","volume":"61","author":"Flamm","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9020090","article-title":"Metal complexes, an untapped source of antibiotic potential?","volume":"9","author":"Frei","year":"2020","journal-title":"Antibiotics"},{"key":"2021013001451338000_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1381612820666140905113336","article-title":"Quorum sensing and biofilms in the pathogen, Streptococcus pneumoniae","volume":"21","author":"Galante","year":"2014","journal-title":"Curr Pharm Des"},{"key":"2021013001451338000_bib57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: Past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"2021013001451338000_bib58","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/652237","article-title":"The 10 \u00d7 \u201820 initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020","volume":"50","author":"Gilbert","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2021013001451338000_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fcimb.2014.00163","article-title":"Pneumococci in biofilms are non-invasive: implications on nasopharyngeal colonization","volume":"4","author":"Gilley","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"2021013001451338000_bib61","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1086\/587942","article-title":"Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis","volume":"197","author":"Grandgirard","year":"2008","journal-title":"J Infect Dis"},{"key":"2021013001451338000_doi50_687_155021","article-title":"Fluorocycline TP-271 is potent against complicated community-acquired bacterial pneumonia pathogens","volume":"2","author":"Grossman","year":"2017","journal-title":"mSphere"},{"key":"2021013001451338000_doi47_905_154821","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1128\/AAC.04354-14","article-title":"Eravacycline (TP-434) is efficacious in animal models of infection","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi46_812_154721","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.06187-11","article-title":"Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic","volume":"56","author":"Grossman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib62","doi-asserted-by":"crossref","first-page":"26538","DOI":"10.1074\/jbc.270.44.26538","article-title":"Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli","volume":"270","author":"Heath","year":"1995","journal-title":"J Biol Chem"},{"key":"2021013001451338000_doi36_860_153921","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/AAC.05382-11","article-title":"Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model","volume":"56","author":"Hegde","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nbt.3037","article-title":"Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice","volume":"33","author":"Henry","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2021013001451338000_bib64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/ars.2012.4765","article-title":"Nitrosothiols in the immune system: signaling and protection","volume":"18","author":"Hernansanz-Agust\u00edn","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"2021013001451338000_bib65","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI30356","article-title":"TRAIL limits excessive host immune responses in bacterial meningitis","volume":"117","author":"Hoffmann","year":"2007","journal-title":"J Clin Invest"},{"key":"2021013001451338000_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/mmi.13029","article-title":"A new quorum-sensing system (TprA\/PhrA) for Streptococcus pneumoniae D39 that regulates a lantibiotic biosynthesis gene cluster","volume":"97","author":"Hoover","year":"2015","journal-title":"Mol Microbiol"},{"key":"2021013001451338000_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1045","article-title":"Safety, tolerability, and immunogenicity of a 20-valent pneumococcal conjugate vaccine (PCV20) in adults 60 to 64 years of qge","author":"Hurley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021013001451338000_bib68","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/ja.2016.35","article-title":"Inhibition of bacterial undecaprenyl pyrophosphate synthase by small fungal molecules","volume":"69","author":"Inokoshi","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"key":"2021013001451338000_bib69","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.20161668","article-title":"pIgR and PEC AM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion","volume":"214","author":"Iovino","year":"2017","journal-title":"J Exp Med"},{"key":"2021013001451338000_bib70","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/infdis\/jiy193","article-title":"Receptor blockade: A novel approach to protect the brain from pneumococcal invasion","volume":"218","author":"Iovino","year":"2018","journal-title":"J Infect Dis"},{"key":"2021013001451338000_bib71","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jac\/dky019","article-title":"Discovery and development of new antibacterial drugs: learning from experience?","volume":"73","author":"Jackson","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2021013001451338000_bib73","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1128\/AAC.00603-13","article-title":"Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against Gram-positive bacteria","volume":"57","author":"Jansen","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib74","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41429-019-0196-6","article-title":"Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria","volume":"72","author":"Jansen","year":"2019","journal-title":"J Antibiot (Tokyo)"},{"key":"2021013001451338000_bib72","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/cb3006424","article-title":"Discovery of small molecule vanin inhibitors: New tools to study metabolism and disease","volume":"8","author":"Jansen","year":"2013","journal-title":"ACS Chem Biol"},{"key":"2021013001451338000_doi12_698_151321","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.bmcl.2018.06.006","article-title":"Synthesis and antibacterial evaluation of novel 11-O-aralkylcarbamoyl-3-O-descladinosylclarithromycin derivatives","volume":"28","author":"Jia","year":"2018","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib65_821_1611049356564","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.bmcl.2017.07.017","article-title":"Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides","volume":"27","author":"Jia","year":"2017","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25122805","article-title":"1-(1-Arylethylpiperidin-4-yl)thymine analogs as antimycobacterial TMPK inhibitors","volume":"25","author":"Jian","year":"2020","journal-title":"Molecules"},{"key":"2021013001451338000_bib76","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1080\/14756366.2019.1662790","article-title":"1-(Piperidin-3-yl)thymine amides as inhibitors of M. tuberculosis thymidylate kinase","volume":"34","author":"Jian","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2021013001451338000_bib77","doi-asserted-by":"crossref","first-page":"e0128532","DOI":"10.1371\/journal.pone.0128532","article-title":"Antimicrobial activity of novel synthetic peptides derived from indolicidin and ranalexin against Streptococcus pneumoniae","volume":"10","author":"Jindal","year":"2015","journal-title":"PLoS One"},{"key":"2021013001451338000_bib78","article-title":"Mechanisms of action and in vivo antibacterial efficacy assessment of five novel hybrid peptides derived from indolicidin and ranalexin against Streptococcus pneumoniae","volume":"2017","author":"Jindal","year":"2017","journal-title":"PeerJ"},{"key":"2021013001451338000_bib80","article-title":"Anthranilic acid inhibitors of Undecaprenyl Pyrophosphate Synthase (UppS), an essential enzyme for bacterial cell wall biosynthesis","volume":"10","author":"Jukic","year":"2019","journal-title":"Front Microbiol"},{"key":"2021013001451338000_bib81","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"2021013001451338000_bib83","article-title":"Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis","volume":"14","author":"Kasanmoentalib","year":"2017","journal-title":"J Neuroinflammation"},{"key":"2021013001451338000_bib84","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0372-y","article-title":"Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: A randomized controlled trial","volume":"12","author":"Kasanmoentalib","year":"2015","journal-title":"J Neuroinflammation"},{"key":"2021013001451338000_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-019-1675-1","article-title":"Complement factor H contributes to mortality in humans and mice with bacterial meningitis","volume":"16","author":"Kasanmoentalib","year":"2019","journal-title":"J Neuroinflammation"},{"key":"2021013001451338000_doi33_844_153721","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jiac.2018.09.003","article-title":"Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria","volume":"25","author":"Kato","year":"2019","journal-title":"J Infect Chemother"},{"key":"2021013001451338000_bib85","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/cb300316n","article-title":"In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compound","volume":"7","author":"Keating","year":"2012","journal-title":"ACS Chem Biol"},{"key":"2021013001451338000_bib86","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s12272-017-0933-y","article-title":"Pneumonia and Streptococcus pneumoniae vaccine","volume":"40","author":"Kim","year":"2017","journal-title":"Arch Pharm Res"},{"key":"2021013001451338000_bib87","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/CMR.00058-15","article-title":"Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: A United States perspective","volume":"29","author":"Kim","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"2021013001451338000_doi48_919_154921","article-title":"Vitro activities and spectrum of the novel fluoroquinolone lascufloxacin (KRP-AM1977)","volume":"61","author":"Kishii","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib88","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1473-3099(02)00450-4","article-title":"Pathogenesis and pathophysiology of pneumococcal meningitis","volume":"2","author":"Koedel","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"2021013001451338000_bib89","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/brain\/awz222","article-title":"Targeting the complement system in bacterial meningitis","volume":"142","author":"Koelman","year":"2019","journal-title":"Brain"},{"key":"2021013001451338000_bib90","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1021\/acs.jmedchem.9b01738","article-title":"Two decades of successful SAR-grounded stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs)","volume":"63","author":"Kolari\u010d","year":"2020","journal-title":"J Med Chem"},{"key":"2021013001451338000_bib91","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/microorganisms8020191","article-title":"Emerging treatment options for infections by multidrug-resistant Gram-positive microorganisms","volume":"8","author":"Koulenti","year":"2020","journal-title":"Microorganisms"},{"key":"2021013001451338000_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154616","article-title":"Generation and improvement of effector function of a novel broadly reactive and protective monoclonal antibody against pneumococcal surface protein A of Streptococcus pneumoniae","volume":"11","author":"Kristian","year":"2016","journal-title":"PLoS One"},{"key":"2021013001451338000_doi16_647_151721","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bmcl.2011.10.101","article-title":"Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens","volume":"22","author":"Kumar","year":"2012","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_doi3_933_155621","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ja.2015.134","article-title":"Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines","volume":"69","author":"Kumura","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"key":"2021013001451338000_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41479-019-0064-y","article-title":"State-of-the-art in the pneumococcal field: Proceedings of the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11)","volume":"12","author":"Kwambana-Adams","year":"2020","journal-title":"Pneumonia"},{"key":"2021013001451338000_bib94","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40291-020-00460-z","article-title":"Use of DAMPs and SAMPs as therapeutic targets or therapeutics: A note of caution","volume":"24","author":"Land","year":"2020","journal-title":"Mol Diagnosis Ther"},{"key":"2021013001451338000_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007898","article-title":"In silico discovery and biological validation of ligands of FAD synthase, a promising new antimicrobial target","volume":"16","author":"Lans","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"2021013001451338000_bib96","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1473-3099(18)30805-3","article-title":"CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial","volume":"19","author":"Laterre","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021013001451338000_bib97","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biologicals.2019.07.005","article-title":"Development of a new 15-valent pneumococcal conjugate vaccine (PCV15) and evaluation of its immunogenicity","volume":"61","author":"Lee","year":"2019","journal-title":"Biologicals"},{"key":"2021013001451338000_bib98","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1021\/bi100523c","article-title":"Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase","volume":"49","author":"Lee","year":"2010","journal-title":"Biochemistry"},{"key":"2021013001451338000_bib99","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.plipres.2005.04.001","article-title":"Coenzyme A: Back in action","volume":"44","author":"Leonardi","year":"2005","journal-title":"Prog Lipid Res"},{"key":"2021013001451338000_bib100","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1128\/AAC.00363-16","article-title":"In vivo pharmacodynamic target investigation of two bacterial topoisomerase inhibitors, ACT-387042 and ACT-292706, in the neutropenic murine thigh model against Streptococcus pneumoniae and Staphylococcus aureus","volume":"60","author":"Lepak","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi51_995_155121","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of a novel aminomethylcycline antibiotic, KBP-7072, in the neutropenic murine pneumonia model against Staphylococcus aureus and Streptococcus pneumoniae","volume":"63","author":"Lepak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib66_602_1611051406289","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejmech.2012.01.023","article-title":"Structure-activity relationships of novel alkylides: 3-O-Arylalkyl clarithromycin derivatives with improved antibacterial activities","volume":"49","author":"Liang","year":"2012","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_doi53_434_155821","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/AAC.01526-13","article-title":"In vivo antibacterial activity of MRX-I, a new oxazolidinone","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi55_661_151421","doi-asserted-by":"crossref","first-page":"17668","DOI":"10.1038\/srep17668","article-title":"\u03b2-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"2021013001451338000_bib101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"2021013001451338000_doi8_963_150621","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejmech.2012.11.028","article-title":"Synthesis and antibacterial evaluation of novel 11,4\u2033-disubstituted azithromycin analogs with greatly improved activity against erythromycin- resistant bacteria","volume":"59","author":"Li","year":"2013","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_bib102","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/23744235.2017.1285046","article-title":"Risk factors for community-acquired bacterial meningitis","volume":"49","author":"Lundbo","year":"2017","journal-title":"Infect Dis (Auckl)"},{"key":"2021013001451338000_bib103","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1574-6976.2006.00024.x","article-title":"Penicillin binding proteins: Key players in bacterial cell cycle and drug resistance processes","volume":"30","author":"Macheboeuf","year":"2006","journal-title":"FEMS Microbiol Rev"},{"key":"2021013001451338000_doi43_309_154521","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi25_659_152621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.02.073","article-title":"Design, synthesis and structure-activity relationships of novel macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl quinolones with highly improved activity against resistant pathogens","volume":"169","author":"Ma","year":"2019","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics5020021","article-title":"Choline binding proteins from Streptococcus pneumoniae: A dual role as enzybiotics and targets for the design of new antimicrobials","volume":"5","author":"Maestro","year":"2016","journal-title":"Antibiotics"},{"key":"2021013001451338000_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: An emerging category of therapeutic agents","volume":"6","author":"Mahlapuu","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"2021013001451338000_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","article-title":"Polyvalent interactions in bioldgical systems: Implications for design and use of multivalent ligands and inhibitors","volume":"37","author":"Mammen","year":"1998","journal-title":"Angew Chem Int Ed Engl"},{"key":"2021013001451338000_bib107","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1021\/jm3011806","article-title":"Discovery of selective and potent inhibitors of Gram-positive bacterial thymidylate kinase (TMK)","volume":"55","author":"Mart\u00ednez-Botella","year":"2012","journal-title":"J Med Chem"},{"key":"2021013001451338000_bib63_943_1611033214296","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejmech.2010.11.035","article-title":"Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4\u2033 elongated arylalkyl groups against macrolide-resistant strains","volume":"46","author":"Ma","year":"2011","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_bib108","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0989-0","article-title":"Inhibition of DAMP signaling as an effective adjunctive treatment strategy in pneumococcal meningitis","volume":"14","author":"Masouris","year":"2017","journal-title":"J Neuroinflammation"},{"key":"2021013001451338000_doi7_979_150421","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1016\/j.ejmech.2011.08.001","article-title":"Novel C-4\u2033 modified azithromycin analogs with remarkably enhanced activity against erythromycin-resistant Streptococcus pneumoniae: The synthesis and antimicrobial evaluation","volume":"46","author":"Ma","year":"2011","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14787210.2019.1550357","article-title":"Teixobactin: a novel anti-infective agent","volume":"17","author":"McCarthy","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2021013001451338000_doi29_142_153221","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/AAC.01123-09","article-title":"In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms","volume":"54","author":"McGhee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_doi39_228_154121","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1128\/AAC.00627-16","article-title":"In vitro activity of lefamulin tested against Streptococcus pneumoniae with defined serotypes, including multidrug-resistant isolates causing lower respiratory tract infections in the United States","volume":"60","author":"Mendes","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib111","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2021013001451338000_bib112","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1021\/jm900625q","article-title":"Discovery of new inhibitors of resistant Streptococcus pneumoniae Penicillin Binding Protein (PBP) 2x by structure-based virtual screening","volume":"52","author":"Miguet","year":"2009","journal-title":"J Med Chem"},{"key":"2021013001451338000_bib113","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.bmcl.2016.03.106","article-title":"Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases","volume":"26","author":"Miles","year":"2016","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib114","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1747-0285.2010.00957.x","article-title":"The use of biochemical and biophysical tools for triage of high-throughput screening hits - aa case study with Escherichia coli phosphopantetheine adenylyltransferase","volume":"75","author":"Miller","year":"2010","journal-title":"Chem Biol Drug Des"},{"key":"2021013001451338000_bib115","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.01181-10","article-title":"Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo","volume":"55","author":"Mills","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib116","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.bmcl.2013.03.047","article-title":"Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV","volume":"23","author":"Mitton-Fry","year":"2013","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib117","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1084\/jem.188.11.2047","article-title":"Characterization of the galU gene of Streptococcus pneumoniae encoding a uridine diphosphoglucose pyrophosphorylase: a gene essential for capsular polysaccharide biosynthesis","volume":"188","author":"Mollerach","year":"1998","journal-title":"J Exp Med"},{"key":"2021013001451338000_bib118","doi-asserted-by":"crossref","first-page":"e36226","DOI":"10.1371\/journal.pone.0036226","article-title":"Burden of disease caused by otitis media: Systematic review and global estimates","volume":"7","author":"Monasta","year":"2012","journal-title":"PLoS One"},{"key":"2021013001451338000_bib119","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1039\/C7DT01350G","article-title":"Reaction mechanism of the metallohydrolase CpsB from: Streptococcus pneumoniae, a promising target for novel antimicrobial agents","volume":"46","author":"Monteiro\u00a0Pedroso","year":"2017","journal-title":"Dalt Trans"},{"key":"2021013001451338000_bib120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.00008-11","article-title":"Pathogenesis and pathophysiology of pneumococcal meningitis","volume":"24","author":"Mook-Kanamori","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2021013001451338000_bib121","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1086\/383352","article-title":"The effect that mutations in the conserved capsular polysaccharide biosynthesis genes cpsA, cpsB, and cpsD have on virulence of Streptococcus pneumoniae","volume":"189","author":"Morona","year":"2004","journal-title":"J Infect Dis"},{"key":"2021013001451338000_doi26_577_153021","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1128\/AAC.01374-09","article-title":"In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone","volume":"54","author":"Morrow","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib122","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/SHK.0000000000000715","article-title":"Augmented passive immunotherapy with p4 peptide improves phagocyte activity in severe sepsis","volume":"46","author":"Morton","year":"2016","journal-title":"Shock"},{"key":"2021013001451338000_bib123","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1128\/JB.00673-06","article-title":"Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion","volume":"188","author":"Moscoso","year":"2006","journal-title":"J Bacteriol"},{"key":"2021013001451338000_bib124","doi-asserted-by":"crossref","first-page":"16555","DOI":"10.1002\/anie.201709313","article-title":"Modulation of quorum sensing in a Gram-positive pathogen by linear molecularly imprinted polymers with anti-infective properties","volume":"56","author":"Motib","year":"2017","journal-title":"Angew Chemie - Int Ed"},{"key":"2021013001451338000_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00326","article-title":"TprA\/PhrA quorum sensing system has a major effect on pneumococcal survival in respiratory tract and blood, and its activity is controlled by CcpA and GlnR","volume":"9","author":"Motib","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2021013001451338000_bib126","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.bmcl.2015.09.075","article-title":"Negishi cross-coupling enabled synthesis of novel NAD+-dependent DNA ligase inhibitors and SAR development","volume":"25","author":"Murphy-Benenato","year":"2015","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib127","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.micpath.2019.03.024","article-title":"Computational screening of potential drug targets for pathogens causing bacterial pneumonia","volume":"130","author":"Nayak","year":"2019","journal-title":"Microb Pathog"},{"key":"2021013001451338000_bib128","doi-asserted-by":"crossref","first-page":"12606","DOI":"10.1002\/chem.201601315","article-title":"New found hope for antibiotic discovery: Lipid II inhibitors","volume":"22","author":"Ng","year":"2016","journal-title":"Chem - A Eur J"},{"key":"2021013001451338000_bib129","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/cc11418","article-title":"The impact of statin use on pneumonia risk and outcome: A combined population-based case-control and cohort study","volume":"16","author":"Nielsen","year":"2012","journal-title":"Crit Care"},{"key":"2021013001451338000_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01543","article-title":"Pneumolysin: Pathogenesis and therapeutic target","volume":"11","author":"Nishimoto","year":"2020","journal-title":"Front Microbiol"},{"key":"2021013001451338000_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800234","article-title":"Inhibiting Pneumococcal surface antigen A (PsaA) with small molecules discovered through virtual screening: Steps toward validating a potential target forStreptococcus pneumoniae","volume":"15","author":"Obaidullah","year":"2018","journal-title":"Chem Biodivers"},{"key":"2021013001451338000_bib132","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1021\/acs.jmedchem.8b00644","article-title":"Design, synthesis, and biological evaluation of novel 7-[(3 aS,7 aS)-3 a-aminohexahydropyrano[3,4- c]pyrrol-2(3 H)-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens","volume":"61","author":"Odagiri","year":"2018","journal-title":"J Med Chem"},{"key":"2021013001451338000_bib133","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1021\/jm301650g","article-title":"Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl- 5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens","volume":"56","author":"Odagiri","year":"2013","journal-title":"J Med Chem"},{"key":"2021013001451338000_bib134","doi-asserted-by":"crossref","first-page":"e0183457","DOI":"10.1371\/journal.pone.0183457","article-title":"Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent","volume":"12","author":"Ogunniyi","year":"2017","journal-title":"PLoS One"},{"key":"2021013001451338000_bib135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.sbi.2007.12.008","article-title":"DNA and RNA ligases: structural variations and shared mechanisms","volume":"18","author":"Pascal","year":"2008","journal-title":"Curr Opin Struct Biol"},{"key":"2021013001451338000_bib136","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0019-2018","article-title":"Streptococcus pneumoniae capsular polysaccharide","volume":"7","author":"Paton","year":"2019","journal-title":"Microbiol Spectr"},{"key":"2021013001451338000_doi40_411_154221","article-title":"Pleuromutilins: Potent drugs for resistant bugs-mode of action and resistance","volume":"7","author":"Paukner","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2021013001451338000_doi38_684_154121","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1128\/AAC.00358-13","article-title":"Antimicrobial activity of the pleuromutilin antibiotic BC-3781 against bacterial pathogens isolated in the SENTRY antimicrobial surveillance program in 2010","volume":"57","author":"Paukner","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib62_711_1611032470826","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bmc.2016.01.055","article-title":"Synthesis and antibacterial evaluation of novel 4\u2032-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens","volume":"24","author":"Pavlovi\u0107","year":"2016","journal-title":"Bioorganic Med Chem"},{"key":"2021013001451338000_doi23_413_152421","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bmcl.2010.10.091","article-title":"Synthesis and antibacterial activity of novel 4-aryl-[1,2,3]-triazole containing macrolides","volume":"21","author":"Pereira","year":"2011","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib137","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/bj3630825","article-title":"Characterization of Streptococcus pneumoniae thymidylate kinase: Steady-state kinetics of the forward reaction and isothermal titration calorimetry","volume":"363","author":"Petit","year":"2002","journal-title":"Biochem J"},{"key":"2021013001451338000_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.01340","article-title":"Interferon-\u03b3 from brain leukocytes enhances meningitis by type 4 Streptococcus pneumoniae","volume":"6","author":"Pettini","year":"2015","journal-title":"Front Microbiol"},{"key":"2021013001451338000_bib139","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17476348.2019.1562339","article-title":"The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance","volume":"13","author":"Peyrani","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2021013001451338000_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01556","article-title":"In vitro activity of robenidine analog NCL195 in combination with outer membrane permeabilizers against gram-negative bacterial pathogens and impact on systemic gram-positive bacterial infection in mice","volume":"11","author":"Pi","year":"2020","journal-title":"Front Microbiol"},{"key":"2021013001451338000_bib141","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/17460913.3.2.205","article-title":"Virulence factors in pneumococcal respiratory pathogenesis","volume":"3","author":"Preston","year":"2008","journal-title":"Future Microbiol"},{"key":"2021013001451338000_bib67_952_1611054911359","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1016\/j.bmcl.2018.09.012","article-title":"Synthesis and antibacterial activity of novel 3-O-arylalkylcarbamoyl-3-O-descladinosyl-9-O-(2-chlorobenzyl)oxime clarithromycin derivatives","volume":"28","author":"Qin","year":"2018","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_doi19_927_152121","author":""},{"key":"2021013001451338000_bib142","article-title":"Envelope structures of Gram-positive bacteria","volume-title":"Current Topics in Microbiology and Immunology","author":"Rajagopal","year":"2017"},{"key":"2021013001451338000_bib143","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10408410802275352","article-title":"Pneumococcal surface adhesin A (PsaA): A review","volume":"34","author":"Rajam","year":"2008","journal-title":"Crit Rev Microbiol"},{"key":"2021013001451338000_bib144","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/CVI.00366-10","article-title":"P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis","volume":"17","author":"Rajam","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2021013001451338000_bib145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.micpath.2007.09.003","article-title":"A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization","volume":"44","author":"Rajam","year":"2008","journal-title":"Microb Pathog"},{"key":"2021013001451338000_bib146","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/597425","article-title":"A 28-aa Pneumococcal Surface Adhesin A\u2013derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection","volume":"199","author":"Rajam","year":"2009","journal-title":"J Infect Dis"},{"key":"2021013001451338000_doi44_645_154621","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/AAC.01589-13","article-title":"A novel ketolide, RBx 14255, with activity against multidrug-resistant Streptococcus pneumoniae","volume":"58","author":"Raj","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112757","article-title":"FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors","volume":"208","author":"Rana","year":"2020","journal-title":"Eur J Med Chem"},{"key":"2021013001451338000_bib148","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3013","article-title":"Anti-virulence strategies to combat bacteria-mediated disease","volume":"9","author":"Rasko","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"2021013001451338000_bib149","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000353439","article-title":"Multivalent choline dendrimers increase phagocytosis of Streptococcus pneumoniae R6 by microglial cells","volume":"59","author":"Ribes","year":"2013","journal-title":"Chemotherapy"},{"key":"2021013001451338000_doi30_436_153321","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1128\/AAC.02316-12","article-title":"Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae","volume":"57","author":"Rodgers","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib150","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/eji.200737357","article-title":"Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression","volume":"37","author":"Roger","year":"2007","journal-title":"Eur J Immunol"},{"key":"2021013001451338000_bib151","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbagen.2018.10.001","article-title":"Widening the antimicrobial spectrum of esters of bicyclic amines: In vitro effect on Gram-positive Streptococcus pneumoniae and Gram-negative non-typeable Haemophilus influenzae biofilms","volume":"1863","author":"Roig-Molina","year":"2019","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"2021013001451338000_doi37_180_154021","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/JCM.01294-12","article-title":"Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics","volume":"50","author":"Ross","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2021013001451338000_bib152","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/JCM.01213-11","article-title":"Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor","volume":"49","author":"Ross","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021013001451338000_doi35_795_153821","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.00170-11","article-title":"Mechanism of action and limited cross-resistance of new lipopeptide MX-2401","volume":"55","author":"Rubinchik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib153","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101469","article-title":"The role of TRAIL\/DRs in the modulation of immune cells and responses","volume":"11","author":"Sag","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2021013001451338000_bib154","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/0929867321666140826115734","article-title":"Peptide deformylase: A new target in antibacterial, antimalarial and anticancer drug discovery","volume":"22","author":"Sangshetti","year":"2014","journal-title":"Curr Med Chem"},{"key":"2021013001451338000_bib155","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.1520727113","article-title":"Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis","volume":"113","author":"Savva","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021013001451338000_bib156","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4161\/viru.20328","article-title":"The potential of nitric oxide releasing therapies as antimicrobial agents","volume":"3","author":"Schairer","year":"2012","journal-title":"Virulence"},{"key":"2021013001451338000_bib157","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14756366.2017.1411910","article-title":"Discovery of antimicrobial compounds targeting bacterial type FAD synthetases","volume":"33","author":"Sebasti\u00e1n","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2021013001451338000_bib158","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07716-5","article-title":"The FAD synthetase from the human pathogen Streptococcus pneumoniae: A bifunctional enzyme exhibiting activity-dependent redox requirements","volume":"7","author":"Sebasti\u00e1n","year":"2017","journal-title":"Sci Rep"},{"key":"2021013001451338000_bib159","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/cid\/ciy1049","article-title":"Low admission plasma gelsolin concentrations identify community-acquired pneumonia patients at high risk for severe outcomes","volume":"69","author":"Self","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021013001451338000_bib160","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2174\/1381612811319140013","article-title":"The prokaryotic FAD synthetase family: A potential drug target","volume":"19","author":"Serrano","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2021013001451338000_doi2_428_155521","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1016\/j.bmcl.2011.09.045","article-title":"Synthesis and antibacterial activity of N 4-mono alkyl derivatives of novel glycopeptide LYV07ww01","volume":"21","author":"Shao","year":"2011","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_doi41_772_154321","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1517\/13543784.8.8.1195","article-title":"Mechanism of action of the oxazolidinone antibacterial agents","volume":"8","author":"Shinabarger","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"2021013001451338000_bib161","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2147\/DDDT.S209238","article-title":"Pharmacokinetics and tolerability of IDP-73152 mesylate after a single oral administration under fasted and fed conditions in healthy volunteers","volume":"13","author":"Shin","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"2021013001451338000_doi58_690_151721","article-title":"Juglone Alleviates Pneumolysin-Induced Human Alveolar Epithelial Cell Injury via Inhibiting the Hemolytic Activity of Pneumolysin","volume":"110","author":"Song","year":"2017","journal-title":"Antonie Van Leeuwenhoek"},{"key":"2021013001451338000_doi59_994_151721","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1111\/jcmm.13179","article-title":"Epigallocatechin gallate inhibits Streptococcus pneumoniae virulence by simultaneously targeting pneumolysin and sortase A","volume":"21","author":"Song","year":"2017","journal-title":"J Cell Mol Med"},{"key":"2021013001451338000_bib162","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acsinfecdis.0c00075","article-title":"Toward a stable and potent coenzyme A-targeting antiplasmodial agent: Structure-activity relationship studies of N-phenethyl-\u03b1-methyl-pantothenamide","volume":"6","author":"Spry","year":"2020","journal-title":"ACS Infect Dis"},{"key":"2021013001451338000_bib163","doi-asserted-by":"crossref","first-page":"e36312","DOI":"10.1371\/journal.pone.0036312","article-title":"Chemical inhibition of bacterial protein tyrosine phosphatase suppresses capsule production","volume":"7","author":"Standish","year":"2012","journal-title":"PLoS One"},{"key":"2021013001451338000_bib164","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20120983","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice","volume":"209","author":"Steinwede","year":"2012","journal-title":"J Exp Med"},{"key":"2021013001451338000_bib165","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.1101413","article-title":"Local delivery of GM-CSF protects mice from lethal pneumococcal pneumonia","volume":"187","author":"Steinwede","year":"2011","journal-title":"J Immunol"},{"key":"2021013001451338000_bib166","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/pbi.12703","article-title":"Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii","volume":"15","author":"Stoffels","year":"2017","journal-title":"Plant Biotechnol J"},{"key":"2021013001451338000_doi21_267_152321","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.bmc.2012.08.007","article-title":"Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as \u201c11a-azalides\u201d","volume":"20","author":"Sugimoto","year":"2012","journal-title":"Bioorganic Med Chem"},{"key":"2021013001451338000_bib167","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/jm501590q","article-title":"Novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-Gram positive activity and improved safety profile","volume":"58","author":"Surivet","year":"2015","journal-title":"J Med Chem"},{"key":"2021013001451338000_bib168","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2011.06323.x","article-title":"Antibiotics in development targeting protein synthesis","volume":"1241","author":"Sutcliffe","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"2021013001451338000_bib169","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: Properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit Rev Microbiol"},{"key":"2021013001451338000_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciz089","article-title":"The Infectious Diseases Society of America's 10 \u00d7 \u201920 initiative (10 new systemic antibacterial agents US Food and Drug Administration approved by 2020): Is 20 \u00d7 \u201920 a possibility?","volume":"69","author":"Talbot","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021013001451338000_bib171","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00579-20","article-title":"Safety and pharmacokinetics of recombinant human plasma gelsolin in patients hospitalized for nonsevere community-acquired pneumonia","volume":"64","author":"Tannous","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2021013001451338000_bib172","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbi.2014.02.020","article-title":"The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis","volume":"40","author":"Too","year":"2014","journal-title":"Brain Behav Immun"},{"key":"2021013001451338000_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019418","article-title":"New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria","volume":"6","author":"Turk","year":"2011","journal-title":"PLoS One"},{"key":"2021013001451338000_bib60_151_1611030384903","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ja.2012.107","article-title":"Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities","volume":"66","author":"Umemura","year":"2013","journal-title":"J Antibiot (Tokyo)"},{"key":"2021013001451338000_bib174","volume-title":"A three-part study to determine the safety, tolerability and pharmacokinetics of GSK1322322 in healthy volunteers and healthy male Japanese subjects","author":"United States National Institute of Health (NIH)","year":"2019"},{"key":"2021013001451338000_bib175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijantimicag.2012.12.001","article-title":"Novel topoisomerase inhibitors: Microbiological characterisation and in vivo efficacy of pyrimidines","volume":"41","author":"Uria-Nickelsen","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2021013001451338000_bib13","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1038\/nrdp.2016.74","article-title":"Community-acquired bacterial meningitis","volume":"2","author":"van\u00a0de\u00a0Beek","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"2021013001451338000_bib109","article-title":"Alternative pathway inhibition by exogenous factor H fails to attenuate inflammation and vascular leakage in experimental pneumococcal sepsis in mice","volume":"11","author":"Van\u00a0Der\u00a0Maten","year":"2016","journal-title":"PLoS One"},{"key":"2021013001451338000_bib178","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/DDDT.S228381","article-title":"In silico design and synthesis of tetrahydropyrimidinones and tetrahydropyrimidinethiones as potential thymidylate kinase inhibitors exerting anti-tb activity against Mycobacterium tuberculosis","volume":"14","author":"Venugopala","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"2021013001451338000_bib179","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1574-6976.2007.00094.x","article-title":"Peptidoglycan structure and architecture","volume":"32","author":"Vollmer","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"2021013001451338000_bib180","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0018-2018","article-title":"The cell wall of Streptococcus pneumoniae","volume":"7","author":"Vollmer","year":"2019","journal-title":"Microbiol Spectr"},{"key":"2021013001451338000_bib181","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1128\/IAI.70.12.7176-7178.2002","article-title":"Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae","volume":"70","author":"Vollmer","year":"2002","journal-title":"Infect Immun"},{"key":"2021013001451338000_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02252","article-title":"Phage lysins for fighting bacterial respiratory infections: A new generation of antimicrobials","volume":"9","author":"V\u00e1zquez","year":"2018","journal-title":"Front Immunol"},{"key":"2021013001451338000_bib177","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3389\/fmicb.2019.01251","article-title":"Synergy between two chimeric lysins to kill Streptococcus pneumoniae","volume":"10","author":"V\u00e1zquez","year":"2019","journal-title":"Front Microbiol"},{"key":"2021013001451338000_bib182","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/jiv028","article-title":"Myeloid-related protein 14 promotes inflammation and injury in meningitis","volume":"212","author":"Wache","year":"2015","journal-title":"J Infect Dis"},{"key":"2021013001451338000_bib183","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.micpath.2017.12.063","article-title":"Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumoniae strain JJA","volume":"115","author":"Wadood","year":"2018","journal-title":"Microb Pathog"},{"key":"2021013001451338000_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00325","article-title":"Room temperature stable PspA-based nanovaccine induces protective immunity","volume":"9","author":"Wagner-Mu\u00f1iz","year":"2018","journal-title":"Front Immunol"},{"key":"2021013001451338000_bib68_994_1611058018601","article-title":"Synthesis and antibacterial evaluation of a series of 11,12-cyclic carbonate azithromycin-3-O-descladinosyl-3-O-carbamoyl glycosyl derivatives","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"2021013001451338000_bib69_536_1611058324998","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1016\/j.bmcl.2017.06.044","article-title":"Synthesis and antibacterial activity of novel 4\u2033-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib185","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/cmdc.201600342","article-title":"Bacterial cell growth inhibitors targeting undecaprenyl diphosphate synthase and undecaprenyl diphosphate phosphatase","volume":"11","author":"Wang","year":"2016","journal-title":"ChemMedChem"},{"key":"2021013001451338000_bib186","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiv262","article-title":"Macrophage migration inhibitory factor is detrimental in pneumococcal pneumonia and a target for therapeutic immunomodulation","volume":"212","author":"Weiser","year":"2015","journal-title":"J Infect Dis"},{"key":"2021013001451338000_bib187","first-page":"51","article-title":"Immune responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination","volume":"3","author":"Westerink","year":"2012","journal-title":"Aging Dis"},{"key":"2021013001451338000_bib188","first-page":"4","article-title":"Management of community-acquired pneumonia in adults: 2016 guideline update from the dutch working party on antibiotic policy (SWAB) and dutch association of chest physicians (NVALT)","volume":"76","author":"Wiersinga","year":"2018","journal-title":"Neth J Med"},{"key":"2021013001451338000_bib189","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI57522","article-title":"Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis","volume":"121","author":"Woehrl","year":"2011","journal-title":"J Clin Invest"},{"key":"2021013001451338000_bib190","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections - Full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2021013001451338000_bib191","article-title":"Pneumonia","author":"World Health Organisation (WHO)","year":"2019"},{"key":"2021013001451338000_bib192","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nature14193","article-title":"Antibiotics: An irresistible newcomer","volume":"517","author":"Wright","year":"2015","journal-title":"Nature"},{"key":"2021013001451338000_bib193","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/156987","article-title":"Sinefungin, a natural nucleoside analogue of S-adenosylmethionine, inhibits Streptococcus pneumoniae biofilm growth","volume":"2014","author":"Yadav","year":"2014","journal-title":"Biomed Res Int"},{"key":"2021013001451338000_bib194","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.micpath.2012.08.003","article-title":"Effect of 5-azacytidine on in vitro biofilm formation of Streptococcus pneumoniae","volume":"53","author":"Yadav","year":"2012","journal-title":"Microb Pathog"},{"key":"2021013001451338000_bib195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139238","article-title":"The small molecule DAM inhibitor, pyrimidinedione, disrupts Streptococcus pneumoniae biofilm growth in vitro","volume":"10","author":"Yadav","year":"2015","journal-title":"PLoS One"},{"key":"2021013001451338000_bib196","article-title":"Chemical interference with iron transport systems to suppress bacterial growth of Streptococcus pneumoniae","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"2021013001451338000_bib197","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jprot.2018.11.021","article-title":"Dirhodium (II) complex interferes with iron-transport system to exert antibacterial action against Streptococcus pneumoniae","volume":"194","author":"Yang","year":"2019","journal-title":"J Proteomics"},{"key":"2021013001451338000_bib198","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/infdis\/jiz353","article-title":"Delayed administration of recombinant plasma gelsolin improves survival in a murine model of penicillin-susceptible and penicillin-resistant pneumococcal pneumonia","volume":"220","author":"Yang","year":"2019","journal-title":"J Infect Dis"},{"key":"2021013001451338000_bib199","doi-asserted-by":"crossref","first-page":"L11","DOI":"10.1152\/ajplung.00094.2015","article-title":"Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function","volume":"309","author":"Yang","year":"2015","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"2021013001451338000_bib200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03711","article-title":"Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target","volume":"3","author":"Yang","year":"2014","journal-title":"Elife"},{"key":"2021013001451338000_bib201","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.micinf.2017.04.002","article-title":"TIGR4 strain causes more severe disease than WU2 strain in a mouse model of Streptococcus pneumoniae meningitis: a common pathogenic role for interferon-\u03b3","volume":"19","author":"Yau","year":"2017","journal-title":"Microbes Infect"},{"key":"2021013001451338000_bib202","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1099\/jmm.0.046052-0","article-title":"Discovery of a compound that acts as a bacterial PyrG (CTP synthase) inhibitor","volume":"61","author":"Yoshida","year":"2012","journal-title":"J Med Microbiol"},{"key":"2021013001451338000_bib203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/14756366.2016.1247055","article-title":"Screening assay for inhibitors of a recombinant Streptococcus pneumoniae UDP-glucose pyrophosphorylase","volume":"32","author":"Zavala","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2021013001451338000_doi32_274_153421","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s40265-016-0667-z","article-title":"Solithromycin: A novel fluoroketolide for the treatment of community-acquired bacterial pneumonia","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"2021013001451338000_doi49_401_154921","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/00003495-200262120-00006","article-title":"The ketolides: A critical review","volume":"62","author":"Zhanel","year":"2002","journal-title":"Drugs"},{"key":"2021013001451338000_bib204","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00894-010-0847-9","article-title":"Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening","volume":"17","author":"Zhang","year":"2011","journal-title":"J Mol Model"},{"key":"2021013001451338000_bib205","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bmcl.2010.12.073","article-title":"Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino\/ methylaminopiperidin-1-yl)fluoroquinolone derivatives","volume":"21","author":"Zhang","year":"2011","journal-title":"Bioorganic Med Chem Lett"},{"key":"2021013001451338000_bib206","doi-asserted-by":"crossref","first-page":"17541","DOI":"10.1074\/jbc.R600004200","article-title":"Inhibiting bacterial fatty acid synthesis","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"2021013001451338000_doi56_886_151521","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/mol.115.100610","article-title":"Verbascoside alleviates pneumococcal pneumonia by reducing pneumolysin oligomers","volume":"89","author":"Zhao","year":"2016","journal-title":"Mol Pharmacol"},{"key":"2021013001451338000_doi57_635_151621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.04.002","article-title":"Shikonin alleviates the biotoxicity produced by pneumococcal pneumolysin","volume":"177","author":"Zhao","year":"2017","journal-title":"Life Sci"},{"key":"2021013001451338000_doi20_508_152221","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ja.2016.42","article-title":"Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives","volume":"69","author":"Zheng","year":"2016","journal-title":"J Antibiot (Tokyo)"},{"key":"2021013001451338000_bib207","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3892\/etm.2016.3536","article-title":"Separation of cordycepin from Cordyceps militaris fermentation supernatant using preparative HPLC and evaluation of its antibacterial activity as an NAD+-dependent DNA ligase inhibitor","volume":"12","author":"Zhou","year":"2016","journal-title":"Exp Ther Med"},{"key":"2021013001451338000_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02146","article-title":"Choline kinase emerges as a promising drug target in gram-positive bacteria","volume":"6","author":"Zimmerman","year":"2019","journal-title":"Front Microbiol"}],"container-title":["FEMS Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsre\/advance-article-pdf\/doi\/10.1093\/femsre\/fuaa072\/36150876\/fuaa072.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/femsre\/advance-article-pdf\/doi\/10.1093\/femsre\/fuaa072\/36150876\/fuaa072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T06:33:33Z","timestamp":1670654013000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsre\/advance-article\/doi\/10.1093\/femsre\/fuaa072\/6064299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":267,"URL":"https:\/\/doi.org\/10.1093\/femsre\/fuaa072","relation":{},"ISSN":["1574-6976"],"issn-type":[{"value":"1574-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"article-number":"fuaa072"}}